Figure 3From: Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trialMean daily rate of TSS reduction in the second phase of the cold. The mean daily rate of TSS reduction was calculated from the variable a2 that was determined by ReWuMod analysis and is shown for the ITT-VP (3A), p = 0.029 and PP-VP populations (3B) p = 0.048. Details describing the ReWuMod analysis are shown in supplementary Figure 1.Back to article page